Freeline Therapeutics Holdings Plc (FRLN) Financials
$6.48
$0.00 (0.00%)As on 29-Feb-2024 09:30EDT
Market cap
$28 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
0.9
Div. Yield
0 %
Income Statement ($ Mln) |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
0.62
|
0.62
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cost of Revenue
|
1.14
|
1.74
|
2.39
|
1.93
|
1.55
|
--
|
|
|
|
|
|
|
Gross Profit
|
-0.51
|
-1.74
|
-2.39
|
-1.93
|
-1.55
|
--
|
|
|
|
|
|
|
Operating Expenses
|
66.19
|
95.29
|
137.91
|
87.18
|
53.05
|
32.72
|
|
|
|
|
|
|
Operating Profit (EBIT)
|
-67.67
|
-98.45
|
-142.38
|
-102.45
|
-63.64
|
-40.98
|
|
|
|
|
|
|
Other Income
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
-73.51
|
-88.60
|
-140.05
|
-96.19
|
-53.77
|
-33.26
|
|
|
|
|
|
|
Provision for Tax
|
0.59
|
0.37
|
0.34
|
0.13
|
0.14
|
0.03
|
|
|
|
|
|
|
Profit after Tax (Net Income)
|
-74.10
|
-88.97
|
-140.39
|
-96.32
|
-53.91
|
-33.28
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
-37.84
|
--
|
-140.39
|
-96.32
|
-53.91
|
-33.28
|
|
|
|
|
|
Liabilities ($ Mln) |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
30.04
|
52.41
|
120.44
|
249.80
|
84.96
|
22.97
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
1.70
|
3.26
|
5.19
|
8.09
|
5.82
|
--
|
|
|
|
|
|
|
Current Liabilities
|
17.48
|
30.97
|
20.68
|
18.81
|
12.43
|
9.16
|
|
|
|
|
|
|
Total Liabilities
|
66.70
|
86.64
|
141.13
|
268.61
|
97.39
|
32.13
|
|
|
|
|
|
Assets ($ Mln) |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
15.22
|
19.01
|
12.83
|
10.44
|
8.34
|
6.05
|
|
|
|
|
|
|
Current Assets
|
34.00
|
67.63
|
128.29
|
258.18
|
89.05
|
26.09
|
|
|
|
|
|
|
Total Assets
|
66.70
|
86.64
|
141.13
|
268.61
|
97.39
|
32.13
|
|
|
|
|
|
|
Total Debt*
|
3.99
|
5.92
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Net Current Assets
|
16.52
|
36.66
|
107.61
|
239.36
|
76.61
|
16.93
|
|
|
|
|
|
Cashflow ($ Mln) |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-78.22
|
-107.56
|
-94.97
|
-52.32
|
-25.77
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
--
|
-4.27
|
-2.39
|
-3.02
|
-3.75
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
27.52
|
-0.98
|
242.62
|
114.59
|
38.13
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Financials Ratios |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash EPS ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Adjusted Book Value ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Free Cash Flow per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Profitability Ratios |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-99.53
|
-75.84
|
-57.55
|
-99.90
|
-289.78
|
|
|
|
|
|
|
ROE (%)
|
-179.73
|
-102.94
|
-75.84
|
-57.55
|
-99.90
|
-144.89
|
|
|
|
|
|
|
ROA (%)
|
-78.33
|
-78.13
|
-68.53
|
-52.63
|
-83.24
|
-103.58
|
|
|
|
|
|
|
EBIT Margin (%)
|
-11,456.11
|
-15,955.75
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Net Margin (%)
|
-11,912.70
|
-14,420.10
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
-0.01
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Growth Ratios |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
EBIT Growth (%)
|
35.21
|
30.86
|
-38.98
|
-60.97
|
-92.25
|
-124.85
|
|
|
|
|
|
|
Net Profit Growth (%)
|
26.40
|
36.63
|
-45.75
|
-78.68
|
-61.97
|
--
|
|
|
|
|
|
|
EPS Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Valuation Ratios |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Price / Book Value
|
0.95
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
-0.05
|
0.43
|
0.88
|
2.70
|
--
|
--
|
|
|
|
|
|
|
Close Price ($)
|
4.30
|
7.13
|
29.70
|
273.90
|
--
|
--
|
|
|
|
|
|
|
High Price ($)
|
12.00
|
39.45
|
281.70
|
325.35
|
--
|
--
|
|
|
|
|
|
|
Low Price ($)
|
2.11
|
6.90
|
28.65
|
219.29
|
--
|
--
|
|
|
|
|
|
|
Market Cap ($ Cr)
|
28.24
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Solvency Ratios |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.11
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Short term debt to equity ratio
|
0.08
|
0.05
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Current Ratio
|
1.95
|
2.18
|
6.20
|
13.72
|
7.16
|
2.85
|
|
|
|
|
|
|
Quick Ratio
|
1.90
|
1.61
|
5.89
|
13.56
|
7.09
|
2.78
|
|
|
|
|
|
|
Interest Coverage
|
-4.76
|
-9.55
|
-31.49
|
-11.37
|
-88.52
|
-219.24
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
453.86
|
199.35
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Asset Turnover
|
0.01
|
0.01
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Receivable days
|
--
|
1,018.50
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Inventory Days
|
--
|
2,525.58
|
725.85
|
371.52
|
172.19
|
--
|
|
|
|
|
|
|
Payable days
|
--
|
1,600.14
|
1,014.87
|
1,317.67
|
878.18
|
--
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
1,943.94
|
--
|
--
|
--
|
--
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
